Reuters logo
4 个月前
BRIEF-BioLineRx to begin late-stage study testing stem cell treatment
2017年5月3日 / 上午11点19分 / 4 个月前

BRIEF-BioLineRx to begin late-stage study testing stem cell treatment

May 3 (Reuters) - Bioline Rx Ltd

* Biolinerx to initiate phase 3 study with bl-8040 as novel stem cell mobilization treatment following successful meeting with fda

* Bioline rx ltd- initiation of phase 3 registrational study expected in second half of the year for bl-8040

* Bioline rx ltd- initiation of phase 3 registrational study expected in second half of this year

* Bioline rx ltd- met with u.s. Fda and has gained clarity on development program and design of a phase 3 pivotal study for bl-8040 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below